Yayın:
Detection of antileishmanial antibodies in blood sampled from blood bank donors in Istanbul

dc.contributor.authorAtes, Sezen Canim
dc.contributor.authorBagirova, Malahat
dc.contributor.authorAllahverdiyev, Adil M.
dc.contributor.authorBaydar, Serap Yesilkir
dc.contributor.authorKoc, Rabia Cakir
dc.contributor.authorElcicek, Serhat
dc.contributor.authorAbamor, Emrah Sefik
dc.contributor.authorOztel, Olga Nehir
dc.contributor.institutionauthorÇAKIR, Rabia
dc.date.accessioned2026-06-27T13:17:22Z
dc.date.issued2012
dc.description.abstractAims: According to the WHO, only 5-20% of the total cases of leishmaniasis are symptomatic leishmaniasis; the other cases are identified as asymptomatic leishmaniasis. In recent studies, it has been demonstrated that donor blood plays an important role in the epidemiology of asymptomatic leishmaniasis. However, the number of the studies on this subject is still insufficient. Additionally, donor blood samples obtained from Istanbul, which is the biggest metropolitan area in Turkey, have not been investigated with regard to Leishmania. Moreover, there is no information about the sensitivity of noninvasive serological methods that are used in the detection of leishmaniasis donor blood samples. Accordingly, this study aimed to investigate the presence of antileishmanial antibodies in blood samples obtained from blood bank donors in Istanbul, by using different serologic methods, and to determine the most sensitive detection method. Materials & methods: Blood samples were taken from 188 healthy blood bank donors to the Capa Turkish Red Crescent Blood Bank (Istanbul, Turkey), and the presence of antileishmanial antibodies was measured by indirect immunofluorescent antibody test (IFAT), ELISA, immunochromatographic dipstick rapid test, and western blot (WB). Results: Antileishmanial antibodies were determined in 12 out of 188 samples by IFAT (6.4%), and six out of these 12 donors were found to be positive at diagnostic titer 1:128 (3.2%). One hundred and eighty eight samples were investigated by ELISA and one (0.5%) of them gave a positive result. None of 188 samples provided a positive result by immunochromatographic test. WB applied to the 12 seroreactive donors showed that three out of 12 donors were positive. Conclusion: In this study, the presence of antileishmanial antibodies in blood samples of blood bank donors from Istanbul has been demonstrated by using feasible and low-cost serological methods. Additionally, in comparison with other simple and low-cost detection methods, WB was used for confirmation. IFAT has a higher sensitivity and therefore may be preferred as a prescreening method in endemic or nonendemic areas.en
dc.description.sponsorshipResearch Foundation of Yildiz Technical University [29-07-04-02]
dc.description.urihttps://doi.org/10.2217/fmb.12.46
dc.identifier.doi10.2217/fmb.12.46
dc.identifier.eissn1746-0921
dc.identifier.endpage779
dc.identifier.issn1746-0913
dc.identifier.issue6
dc.identifier.pubmed22702529
dc.identifier.startpage773
dc.identifier.urihttps://hdl.handle.net/20.500.14981/51512
dc.identifier.volume7
dc.identifier.wos000305658600012
dc.language.isoeng
dc.publisherFUTURE MEDICINE LTD
dc.relation.ispartofFUTURE MICROBIOLOGY
dc.subjectblood donors
dc.subjectELISA
dc.subjectimmunochromatographic dipstick rapid test
dc.subjectimmunofluorescence antibody test
dc.subjectleishmaniasis
dc.subjectwestern blot
dc.subjectVISCERAL LEISHMANIASIS
dc.subjectCANINE LEISHMANIASIS
dc.subjectBALEARIC-ISLANDS
dc.subjectDIAGNOSTIC-TESTS
dc.subjectKALA-AZAR
dc.subjectINFANTUM
dc.subjectTRANSMISSION
dc.subjectTRANSFUSION
dc.subjectINFECTION
dc.subjectDONOVANI
dc.subjectMicrobiology
dc.titleDetection of antileishmanial antibodies in blood sampled from blood bank donors in Istanbul
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar